Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc is a leading distributor of life science products and services primarily to the biopharmaceutical industry.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Maravai's stock with a target price of $10.69, indicating significant growth potential.
Financial Health
Maravai LifeSciences is performing well with good revenue and cash flow, indicating strong business operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring MRVI
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
mRNA & Gene Tools
Maravai supplies building blocks for mRNA and gene‑editing work, a sector with durable scientific interest — though demand can ebb with funding cycles.
Contract Manufacturing Growth
Its CDMO-like services tap growth as firms outsource production, but revenue can be lumpy and tied to a few large customers.
Steady R&D Momentum
Ongoing investment in R&D and product breadth can sustain long-term relevance; investors should weigh this against competition and operational risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
